ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Efficacy and safety of Duhuo-Jisheng decoction in rheumatoid arthritis: A systematic review and meta-analysis of 42 randomized controlled trials

Qu, Pengda; Wang, Haiyang; Wang, Wei; Du, Shiyu; Peng, Zhaorong; Hu, Qian; Tang, Xiaohu*云南大学; 1
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries2023-11-3DOI: 10.1097/MD.0000000000035513
9阅读
引用收藏
分享

摘要

Background:Duhuo-Jisheng decoction (DJD) is a Chinese herb formula. Previous studies have reported that the clinical symptoms and laboratory indicators of rheumatoid arthritis (RA) patients could be improved by DJD. However, the existing evidence was not robust enough and controversial.Methods:Randomized controlled trials of DJD for RA were retrieved from Chinese and English databases from their inception to April 16, 2023. Meta-analysis was performed by Stata 17 software. We used subgroup analysis, meta-regression, and sensitivity analysis to identify potential sources of heterogeneity. The subgroup analysis and meta-regression were conducted from 6 aspects, including age, course of disease, course of treatment, interventions used in the experimental or control group, and random sequence generation. Galbraith plot was used to find studies with possible heterogeneity. Publication bias was assessed by Egger's test and funnel plots when the number of relevant studies was greater than or equal to 10.Results:Forty-two studies were included, involving 3635 patients and 19 outcome indicators. Meta-analysis showed that, compared with the routine disease-modifying antirheumatic drugs (rDMARDs), DJD could better improve the level of laboratory indicators, main symptoms and signs, and questionnaire scores of RA patients. The laboratory indicators included rheumatoid factor, T lymphocyte subpopulation (including CD4+, CD8+, and CD4+/CD8+), and inflammatory biomarkers (including erythrocyte sedimentation rate, C-reactive protein, tumor necrosis factor-alpha, interleukin 6, interleukin 1 beta, and interleukin 1). The main symptoms and signs included the duration of morning stiffness, the number of joint tenderness, the number of swollen joints, and the grip strength of both hands. The questionnaire included visual analogue scale, health assessment questionnaire, and disease activity score in 28 joints. In addition, the adverse events of DJD treatment were significantly lower than those of rDMARDs. However, the results of a few subgroup analyses differed from the overall results. Furthermore, the publication bias assessment showed that, out of 11 evaluated results, 4 had publication bias.Conclusion:DJD could be a satisfactory complementary and alternative therapy for RA. However, due to a small number of subgroup analysis results being different from the overall results, it should be verified by further studies.

学科与关键词

关键词
Duhuo-Jisheng decoctionmeta-analysisrheumatoid arthritissystematic reviewtraditional Chinese medicine
相关
加载中…
  • Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysis
    Han, Rong; Ren, Hong Cheng; Zhou, Sitong; Gu, Sherman; Gu, Yue-Yu; Sze, Daniel Man-yuen*; Chen, Meng-Hua*JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE, 2022, 12(5): 437-446.被引 8
  • Efficacy of Duhuo Jisheng Decoction for Treating Cold-Dampness Obstruction Syndrome-Type Knee Osteoarthritis: A Pooled Analysis
    Zhao, Jinlong; Liang, Guihong; Pan, Jianke; Yang, Weiyi; Zeng, Lingfeng*; Liu, Jun*Biomed Research International, 2022, 2022: 2350404.被引 8
  • Real-world effects of Yishen Tongbi decoction for rheumatoid arthritis: protocol for a prospective, observational, multicenter cohort study with validation against double-blind, randomized, controlled trial
    Liu, Lijuan; Zhu, Fangfang; Xin, Yijun; Zhang, Lu; Hu, Congqi; Xu, Yanping; Zhang, Jinming; Liu, Lingjie; Chen, Guangxing*Frontiers in Pharmacology, 2024, 15: 1320578.
查看全部 →

发表信息

论文状态
公开发表
期刊
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
发表日期
2023-11-03
卷期
第 102 卷, 第 44 期
页码
e35513
DOI
10.1097/MD.0000000000035513
语言
ENGLISH
成果收录
SCIE
资助标注
Yunnan Provincial Department of Education Science Research Fund Project [2022Y362]; Famous Doctor Special Project for Ten Thousand Talent Plans of Yunnan Province [1]; Project of First-class Discipline Construction in Yunnan Province [2022YB02]

作者

  • Q

    Qu, Pengda (第一作者)

    1 · yunnan univ

  • W

    Wang, Haiyang

    1 · yunnan univ

查看全部 7 位作者收起作者
  • W

    Wang, Wei

    yunnan univ

  • D

    Du, Shiyu

    1 · yunnan univ

  • P

    Peng, Zhaorong

    1 · yunnan univ

  • H

    Hu, Qian

    yunnan univ

  • T

    Tang, Xiaohu (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417